<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Microcephaly in infants and children: Etiology and evaluation</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Microcephaly in infants and children: Etiology and evaluation</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Microcephaly in infants and children: Etiology and evaluation</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Julie A Boom, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jan E Drutz, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Helen V Firth, DM, FRCP, FMedSci</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Diane Blake, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 15, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The measurement of head circumference (also called occipitofrontal circumference [OFC]), a direct reflection of head growth, is an important step in the evaluation of childhood growth and development. Deviations from normal head growth may be the first indication of an underlying congenital, genetic, or acquired problem (eg, congenital infection, genetic syndrome) [<a href="#rid1">1-4</a>]. Many genetic conditions are associated with an abnormal pattern of head growth; the earlier these conditions are detected, the earlier appropriate treatment, services, and genetic counseling can be provided [<a href="#rid5">5</a>].</p><p>The etiology and evaluation of microcephaly in infants and children will be reviewed here. The etiology and evaluation of macrocephaly and the clinical genetics approach to microcephaly are discussed separately. (See  <a class="medical medical_review" href="/d/html/14392.html" rel="external">"Microcephaly: A clinical genetics approach"</a> and  <a class="medical medical_review" href="/d/html/2849.html" rel="external">"Macrocephaly in infants and children: Etiology and evaluation", section on 'Etiology'</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">MONITORING HEAD GROWTH</span><span class="headingEndMark"> — </span>Occipitofrontal circumference (OFC) should be measured at health maintenance visits between birth and three years of age and in any child with neurologic symptoms or developmental complaints. The technique for measuring head circumference  (<a class="graphic graphic_picture graphicRef70799" href="/d/graphic/70799.html" rel="external">picture 1</a>) is discussed separately. (See  <a class="medical medical_review" href="/d/html/2865.html" rel="external">"The pediatric physical examination: General principles and standard measurements", section on 'Head circumference'</a>.)</p><p>OFC measurements are most informative when plotted over time [<a href="#rid6">6</a>]. Normal head growth in infants and children and reference standards for monitoring head growth in healthy children are discussed separately. In the United States, the Centers for Disease Control and Prevention (CDC) recommend that the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.who.int%2Ftoolkits%2Fchild-growth-standards%2Fstandards&amp;token=mr3MkQMxxRm373pPGLTYB6lEv8T2h1BSRo3qIw7gt38Q057dFRQVJ89Vy4aOBmJF8XlYlyWxepnTr9ASr67UNw%3D%3D&amp;TOPIC_ID=2839" target="_blank">World Health Organization growth standards</a> ( (<a class="graphic graphic_figure graphicRef58632 graphicRef74503" href="/d/graphic/58632.html" rel="external">figure 1A-B</a>) and (<a class="calc calc_professional" href="/d/html/15630.html" rel="external">calculator 1</a>)) be used for children age zero to two years and the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fgrowthcharts%2Fcdc_charts.htm&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLMtEcNWPM8WxZItFO808GkzUyw1gyf1LadKIGm99AkTi6m4mxc5JY8HjMjDSva9IOg%3D%3D&amp;TOPIC_ID=2839" target="_blank">CDC growth charts</a> ( (<a class="graphic graphic_figure graphicRef80863 graphicRef59076" href="/d/graphic/80863.html" rel="external">figure 2A-B</a>) and (<a class="calc calc_professional" href="/d/html/13417.html" rel="external">calculator 2</a>)) be used for children age two to three years [<a href="#rid7">7</a>]. Head circumference charts for older children and adults are provided separately. (See  <a class="medical medical_review" href="/d/html/2845.html" rel="external">"Normal growth patterns in infants and prepubertal children", section on 'Head growth'</a> and  <a class="medical medical_review" href="/d/html/2865.html" rel="external">"The pediatric physical examination: General principles and standard measurements", section on 'Head circumference'</a>.)</p><p class="headingAnchor" id="H5"><span class="h1">DEFINITIONS</span></p><p class="headingAnchor" id="H6"><span class="h2">Microcephaly</span><span class="headingEndMark"> — </span>Given that microcephaly is a sign rather than a diagnosis, we define microcephaly with qualifying terms:</p><p class="bulletIndent1"><span class="glyph">●</span>Borderline microcephaly – Occipitofrontal circumference (OFC) between 2 and 3 standard deviations (SD) below the mean for age, sex, and gestation</p><p class="bulletIndent1"><span class="glyph">●</span>Moderate microcephaly – OFC between 3 and 5 SD below the mean for age, sex, and gestation</p><p class="bulletIndent1"><span class="glyph">●</span>Severe microcephaly – OFC ≥5 SD below the mean for age, sex, and gestation</p><p></p><p>However, the definition of microcephaly is somewhat controversial [<a href="#rid8">8-11</a>]. Some authors define microcephaly as an OFC more than 2 SD below the mean (ie, &lt;3<sup>rd</sup> percentile) [<a href="#rid5">5,6,12</a>]. Some require that the measurement be adjusted as necessary for prematurity or parental head circumference [<a href="#rid10">10,13</a>]. Other authors define microcephaly as an OFC more than 3 SD below the mean [<a href="#rid14">14-17</a>]. Still others introduce qualifying terms: mild microcephaly or borderline microcephaly (between 2 and 3 SD below the mean), and severe microcephaly (more than 3 SD below the mean) [<a href="#rid18">18</a>]. The American Academy of Neurology practice parameter defines microcephaly as OFC &gt;2 SD below the mean [<a href="#rid11">11</a>]. These distinctions are somewhat related to prognosis, as described below [<a href="#rid14">14,19-21</a>]. (See <a class="local">'Associated neurologic impairment'</a> below.)</p><p>The definition of microcephaly in the evaluation of infants for congenital Zika virus infection is discussed separately. (See  <a class="medical medical_review" href="/d/html/109681.html" rel="external">"Congenital Zika virus infection: Clinical features, evaluation, and management of the neonate", section on 'Assessment for microcephaly'</a>.)</p><p>Using the definition of more than 2 SD below the mean, approximately 2 percent of the general population would be considered microcephalic even though many of these individuals are simply at the low end of the population distribution [<a href="#rid8">8,22</a>].</p><p class="headingAnchor" id="H8"><span class="h2">Microencephaly</span><span class="headingEndMark"> — </span>Microencephaly (micrencephaly) is an abnormally small brain. Microencephaly is a neuroimaging or neuropathologic diagnosis [<a href="#rid23">23</a>]. However, because head growth is driven by brain growth, microcephaly usually implies microencephaly (except in cases of generalized craniosynostosis in which skull growth is restricted) [<a href="#rid9">9,12,16,18,23</a>]. (See  <a class="medical medical_review" href="/d/html/2910.html" rel="external">"Overview of craniosynostosis"</a>.)</p><p>Although microcephaly always implies microencephaly [<a href="#rid5">5</a>], the reverse is not true. Microencephaly may be present in children with normal OFC [<a href="#rid23">23</a>].</p><p class="headingAnchor" id="H4147604864"><span class="h1">CLASSIFICATION</span><span class="headingEndMark"> — </span>Microcephaly can be classified in a number of ways [<a href="#rid8">8-10,15,24</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>By time of onset – Congenital microcephaly is present at birth or by 36 weeks gestation. It is sometimes called "primary microcephaly," but "primary microcephaly" also refers to a particular microcephaly phenotype, so "congenital microcephaly" is preferred. (See  <a class="medical medical_review" href="/d/html/14392.html" rel="external">"Microcephaly: A clinical genetics approach", section on 'Terminology'</a>.)</p><p></p><p class="bulletIndent1">Postnatal microcephaly refers to failure of normal growth in a brain that was of normal size at birth. It is sometimes called "secondary microcephaly." Time of onset is the most commonly used classification system.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>By etiology – Genetic or environmental. (See <a class="local">'Etiology'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>By relation to other growth parameters – Symmetric (proportionate) or asymmetric (disproportionate). Microcephaly is considered symmetric (or proportionate) when the OFC is more than 2 to 3 standard deviations (SD) below the mean but proportionate to weight and length (or height), which also are below the mean [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>By association with other anomalies – Isolated (or pure) microcephaly is not associated with any other anomalies. Syndromal (or complex) microcephaly is associated with one or more additional anomalies  (<a class="graphic graphic_table graphicRef61045" href="/d/graphic/61045.html" rel="external">table 1</a>). These categories tend to overlap.</p><p></p><p class="headingAnchor" id="H9"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Microcephaly has two major mechanisms:</p><p class="bulletIndent1"><span class="glyph">●</span>Lack of brain development or abnormal brain development related to a developmental insult during the time-specific period of induction and major cellular migration [<a href="#rid23">23</a>]; this type of microcephaly is thought to result from a reduction in the number of neurons generated during neurogenesis [<a href="#rid16">16</a>]; the forebrain is most severely affected (eg, holoprosencephaly) [<a href="#rid14">14</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Injury or insult to a previously normal brain (sometimes called secondary microcephaly); this type of microcephaly is thought to result from a reduction in the number of dendritic processes and synaptic connections [<a href="#rid16">16</a>]</p><p></p><p class="headingAnchor" id="H10"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>A variety of genetic abnormalities and environmental insults can affect brain development, resulting in microencephaly and/or microcephaly of congenital or postnatal onset  (<a class="graphic graphic_table graphicRef75479" href="/d/graphic/75479.html" rel="external">table 2</a>) [<a href="#rid23">23,25</a>].</p><p>In a retrospective series of 680 children with microcephaly who presented for pediatric neurology evaluation at two centers in Germany, the etiologic distribution was as follows [<a href="#rid26">26</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Genetic or presumably genetic (eg, numerical chromosome aberrations, microdeletions/duplications, monogenic disorders, genetic syndromes) – 29 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Prenatal and perinatal brain injury (eg, teratogenic exposure, maternal disease, birth complication) – 27 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Craniosynostosis – 2 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Postnatal brain injury (eg, infarct, encephalitis, nonaccidental trauma) – 2 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Unknown etiology – 41 percent (it is likely that many of these patients had a genetic etiology)</p><p></p><p>The majority of patients in this series had neurologic findings (eg, intellectual disability, epilepsy). The distribution of causes in primary care patients is likely to differ. A smaller, but similar, retrospective review of 197 Australian newborns with microcephaly demonstrated that 98 percent presented with congenital anomalies, 73 percent had abnormal central nervous system (CNS) imaging, and 51 percent had an abnormal chromosomal microarray, with 23 percent having a known genetic cause [<a href="#rid27">27</a>]. Fifteen percent of the children in this cohort died by five years.</p><p class="headingAnchor" id="H11"><span class="h2">Isolated microcephaly</span><span class="headingEndMark"> — </span>Isolated microcephaly ("microcephaly vera," "primary microcephaly," or "true microcephaly") is present at birth and uncomplicated by anomalies outside the brain. The brain may have normal architecture but is small (more than 3 standard deviations [SD] below the mean) [<a href="#rid8">8</a>]. Isolated microcephaly is discussed separately. (See  <a class="medical medical_review" href="/d/html/14392.html" rel="external">"Microcephaly: A clinical genetics approach", section on 'Primary genetic microcephaly and its syndromes'</a>.)</p><p class="headingAnchor" id="H12"><span class="h2">Syndromic microcephaly</span><span class="headingEndMark"> — </span>Numerous syndromes have microcephaly as one of their features [<a href="#rid8">8</a>]. A complete listing or description of such syndromes is beyond the scope of this review. However, <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fomim%2F&amp;token=wEsKVFvqlKzpT%2BqOtddW%2F1mEzbrra1EyPWuMKBWRSz2CpYoyP348HDYHpSCw69NK&amp;TOPIC_ID=2839" target="_blank">Online Mendelian Inheritance in Man</a> is an online database that permits searching according to combinations of clinical features (eg, microcephaly, syndactyly, cataracts). Select microcephaly syndromes that have recognizable phenotypes are described in the table  (<a class="graphic graphic_table graphicRef61045" href="/d/graphic/61045.html" rel="external">table 1</a>) [<a href="#rid8">8,15</a>]. Syndromic microcephaly is discussed separately. (See  <a class="medical medical_review" href="/d/html/14392.html" rel="external">"Microcephaly: A clinical genetics approach", section on 'Microcephaly with dysmorphism'</a>.)</p><p class="headingAnchor" id="H13"><span class="h2">Neuroanatomic abnormalities</span><span class="headingEndMark"> — </span>Neuroanatomic abnormalities that are associated with microcephaly include neural tube defects, holoprosencephaly, atelencephaly, lissencephaly, schizencephaly, polymicrogyria, macrogyria, and fetal brain disruption sequence [<a href="#rid5">5</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neural tube defects</strong> – Encephalocele (protrusion of a portion of the cerebral hemisphere or meninges through a skull defect) or spinal neural tube defects can be associated with abnormal development of the brain and microcephaly. (See  <a class="medical medical_review" href="/d/html/6171.html" rel="external">"Primary (congenital) encephalocele"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Holoprosencephaly</strong> – Holoprosencephaly results from incomplete development and septation of the midline CNS structures. It may occur as an isolated abnormality, in association with other brain defects, or as part of a multiple-anomalies syndrome [<a href="#rid8">8</a>]. It is characterized by varying degrees of brain separation, hypotelorism, facial clefts, and nasal malformations  (<a class="graphic graphic_figure graphicRef70880" href="/d/graphic/70880.html" rel="external">figure 3</a>). The clinical manifestations range from an isolated single maxillary incisor to cebocephaly (eg, small mouth, single nostril, and close-set eyes  (<a class="graphic graphic_picture graphicRef60138" href="/d/graphic/60138.html" rel="external">picture 2</a>)) or cyclopia. (See  <a class="medical medical_review" href="/d/html/2920.html" rel="external">"Overview of craniofacial clefts and holoprosencephaly", section on 'Holoprosencephaly'</a> and  <a class="medical medical_review" href="/d/html/6301.html" rel="external">"Congenital anomalies of the nose", section on 'Holoprosencephaly'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Atelencephaly</strong> – Atelencephaly (or aprosencephaly) is a rare brain malformation without any telencephalon-derived brain structures (the cerebrum and related structures) [<a href="#rid28">28</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lissencephaly</strong> – In lissencephaly, the six cortical layers do not form normally due to impaired migration of neurons from the germinal matrix lining the ventricles. The surface of the brain appears completely or partially smooth with loss or reduction of sulci  (<a class="graphic graphic_diagnosticimage graphicRef67398 graphicRef119114" href="/d/graphic/67398.html" rel="external">image 1A-B</a>) [<a href="#rid9">9</a>]. Lissencephaly is usually genetic in origin but may also be caused by infection or intrauterine perfusion failure. Microcephaly develops in all patients with lissencephaly by the first year; a minority is microcephalic at birth [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pachygyria</strong> – Pachygyria (macrogyria) is a developmental malformation characterized by a reduction in the number of sulci of the cerebrum and is often seen in lissencephaly.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Schizencephaly</strong> – Schizencephaly is characterized by asymmetric infolding of cortical gray matter along the primary brain cleft in the perisylvian region  (<a class="graphic graphic_diagnosticimage graphicRef74979 graphicRef141533 graphicRef119116" href="/d/graphic/74979.html" rel="external">image 2A-C</a>) [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Polymicrogyria</strong> – Polymicrogyria is a developmental malformation characterized by excessive gyri on the surface of the brain  (<a class="graphic graphic_diagnosticimage graphicRef57657 graphicRef119117" href="/d/graphic/57657.html" rel="external">image 3A-B</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fetal brain disruption sequence</strong> – Fetal brain disruption sequence is characterized by severe microcephaly of prenatal onset (average occipitofrontal circumference [OFC] 5.8 SD below the mean), overlapping cranial sutures, prominence of the occipital bone, and scalp rugae [<a href="#rid18">18,29-33</a>]. It is thought to result from destruction or necrosis of the brain tissue secondary to prenatal insult (eg, vascular disruption, intrauterine infection) some of which may be genetic in origin (eg, mutations in COL4A1/2) [<a href="#rid33">33</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hydranencephaly</strong> – Hydranencephaly is vascular insult to the brain in which fluid-filled cavities replace the cerebral hemispheres; cerebellum, midbrain, thalami, and basal ganglia are usually preserved.</p><p></p><p class="headingAnchor" id="H14"><span class="h2">Metabolic disorders</span><span class="headingEndMark"> — </span>Various metabolic disorders may be associated with microcephaly, but the prevalence of metabolic disorders among children with microcephaly is low (estimated to be 1 to 5 percent) [<a href="#rid11">11</a>]. Metabolic disorders associated with microcephaly include aminoacidurias (eg, phenylketonuria [PKU]), organic acidurias (eg, methylmalonic aciduria), urea cycle disorders (eg, citrullinemia), and certain storage diseases (eg, neuronal ceroid lipofuscinosis)  (<a class="graphic graphic_table graphicRef75479" href="/d/graphic/75479.html" rel="external">table 2</a>). With the exception of maternal PKU, phosphoglycerate dehydrogenase deficiency, and Amish lethal microcephaly, metabolic disorders rarely present with microcephaly [<a href="#rid11">11</a>].</p><p class="headingAnchor" id="H15"><span class="h2">Environmental factors</span><span class="headingEndMark"> — </span>Environmental factors that may result in decreased brain size include [<a href="#rid5">5,18,19,24,34,35</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Antenatal, perinatal, and postnatal CNS system infections (see  <a class="medical medical_review" href="/d/html/6011.html" rel="external">"Overview of TORCH infections", section on 'Clinical features of TORCH infections'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In utero drug or toxin exposure – Characteristic features of fetal alcohol exposure include pre- and postnatal growth retardation, short palpebral fissures, flat philtrum, and thin upper lip (see  <a class="medical medical_review" href="/d/html/14381.html" rel="external">"Fetal alcohol spectrum disorder: Clinical features and diagnosis", section on 'Clinical features'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypoxic-ischemic insults (prenatal or postnatal) (see  <a class="medical medical_review" href="/d/html/6205.html" rel="external">"Etiology and pathogenesis of neonatal encephalopathy"</a> and  <a class="medical medical_review" href="/d/html/6216.html" rel="external">"Clinical features, diagnosis, and treatment of neonatal encephalopathy"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intraventricular hemorrhage or stroke resulting in ischemic destruction (see  <a class="medical medical_review" href="/d/html/5051.html" rel="external">"Germinal matrix and intraventricular hemorrhage (GMH-IVH) in the newborn: Risk factors, clinical features, screening, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6157.html" rel="external">"Stroke in the newborn: Classification, manifestations, and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe malnutrition (postnatal) [<a href="#rid36">36</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Systemic disease that is often genetic in origin (eg, polycystic kidneys, biliary atresia, renal failure)</p><p></p><p class="headingAnchor" id="H16"><span class="h1">POSTNATAL EVALUATION</span></p><p class="headingAnchor" id="H17"><span class="h2">Overview of approach</span><span class="headingEndMark"> — </span>Evaluation for microcephaly should be initiated when a single occipitofrontal circumference (OFC) measurement is more than 2 to 3 standard deviations (SD) below the mean or when serial measurements reveal progressive decrease in head size (ie, crossing of ≥2 major percentile lines [eg, 10<sup>th</sup>, 25<sup>th</sup>, 50<sup>th</sup>, 75<sup>th</sup>, 90<sup>th</sup>] between health supervision visits) [<a href="#rid14">14</a>].</p><p>The evaluation of microcephaly includes a thorough history and physical examination of the child and parents (in consideration of familial variation in head size) [<a href="#rid6">6,9,11,14,15,26</a>]. (See <a class="local">'History'</a> below and <a class="local">'Physical examination'</a> below and <a class="local">'Parental OFC and Weaver curve'</a> below.)</p><p>Ancillary testing, which is directed by clinical findings from the history and examination, may include laboratory studies and imaging  (<a class="graphic graphic_algorithm graphicRef94816" href="/d/graphic/94816.html" rel="external">algorithm 1</a>). (See <a class="local">'Diagnostic testing'</a> below and <a class="local">'Neuroimaging'</a> below.)</p><p>Factors that determine the need for laboratory and radiologic evaluation include:</p><p class="bulletIndent1"><span class="glyph">●</span>Age at onset, although the birth OFC measurement often is not available </p><p class="bulletIndent1"><span class="glyph">●</span>History of antenatal insult (infection, toxin, drug)  (<a class="graphic graphic_table graphicRef75479" href="/d/graphic/75479.html" rel="external">table 2</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Associated features (eg, proportionality, syndromic features)</p><p class="bulletIndent1"><span class="glyph">●</span>Family history</p><p></p><p>The approach outlined below is largely consistent with that outlined in the practice parameter developed by the American Academy of Neurology and the Child Neurology Society [<a href="#rid11">11</a>].</p><p class="headingAnchor" id="H18"><span class="h3">Syndromic features or signs of metabolic disease</span><span class="headingEndMark"> — </span>If syndromic features  (<a class="graphic graphic_table graphicRef61045" href="/d/graphic/61045.html" rel="external">table 1</a>) or symptoms of metabolic disease are present, consultation with, or referral to, a clinical geneticist should be initiated to determine the appropriate diagnostic evaluation. (See <a class="local">'Diagnostic testing'</a> below and  <a class="medical medical_review" href="/d/html/14392.html" rel="external">"Microcephaly: A clinical genetics approach", section on 'Initial genetics consultation'</a>.)</p><p class="headingAnchor" id="H19"><span class="h3">No syndromic features and normal development</span><span class="headingEndMark"> — </span>For<strong> </strong>children without syndromic features or symptoms of metabolic disease and who have normal development, our evaluation varies with the severity of microcephaly:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>OFC more than 3 SD below the mean</strong> – If syndromic features are absent and the OFC was more than 3 SD below the mean at birth (ie, congenital microcephaly), evaluation for congenital infection and neuroimaging may be warranted [<a href="#rid14">14,15,37</a>]. If neuroanatomy is normal, additional evaluation for primary microcephaly may be warranted. (See  <a class="medical medical_review" href="/d/html/14392.html" rel="external">"Microcephaly: A clinical genetics approach", section on 'Primary genetic microcephaly and its syndromes'</a>.)</p><p></p><p class="bulletIndent1">If syndromic features are absent and the OFC is more than 3 SD below the mean with postnatal onset, neuroimaging may be warranted.</p><p></p><p class="bulletIndent1">Consultation with, or referral to, a specialist in pediatric infectious diseases, pediatric genetics, pediatric neurology, and/or pediatric radiologist may be helpful in planning the diagnostic evaluation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>OFC 2 to 3 SD below the mean</strong> – If syndromic features are absent and the OFC is between 2 and 3 SD below the mean, measurement of the child's height and weight is important to distinguish proportionate growth retardation from microcephaly.</p><p></p><p class="bulletIndent1">Parental head circumference is helpful in evaluating familial microcephaly [<a href="#rid15">15</a>]. (See <a class="local">'Parental OFC and Weaver curve'</a> below.)</p><p></p><p class="headingAnchor" id="H20"><span class="h3">No syndromic features and abnormal development</span><span class="headingEndMark"> — </span>Additional evaluation (ie, neuroimaging or diagnostic testing) may be warranted in children with microcephaly, no syndromic features, and abnormal or delayed development that requires intervention. Testing may include genetic studies and evaluation for congenital infection. Consultation with a clinical geneticist, specialist in pediatric infectious diseases, or pediatric neurology is suggested to determine the most appropriate testing strategy.</p><p class="headingAnchor" id="H21"><span class="h2">History</span><span class="headingEndMark"> — </span>Important aspects of the history in a child with microcephaly include [<a href="#rid6">6,8,11,15,26</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Prenatal history, particularly with respect to maternal medical problems (eg, diabetes, epilepsy, phenylketonuria [PKU]), medications, infections, tobacco, alcohol, or substance use, radiation exposure; findings of antenatal ultrasonography if it was performed. (See <a class="local">'Environmental factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Birth history (eg, perinatal complications, infections, metabolic issues). (See <a class="local">'Environmental factors'</a> above and <a class="local">'Metabolic disorders'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Weight, length, and OFC at birth to establish the onset of microcephaly and to determine if it is proportionate to weight and length. (See <a class="local">'Classification'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>OFC trajectory to determine whether microcephaly is static or progressive (ie, OFC decreases over time from above the second percentile to below it). The pattern of head growth may suggest the etiology. In a retrospective review of 51 children, causes of progressive microcephaly included idiopathic, familial, syndromic, post-pathogenic event, and mixed [<a href="#rid38">38</a>]. Neither the trajectory nor the cause predicted the child's developmental or intellectual outcome.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>History of seizures, developmental history (regression of milestones may indicate metabolic disease).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Family history of consanguinity or similarly affected individuals. The family history should include three generations to detect recessive disorders, which may skip a generation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For children who were born prematurely, abnormal head ultrasonography findings. In a retrospective review of 923 preterm infants (&lt;28 weeks), microcephaly at age two years was more common among those with intraventricular hemorrhage, ventriculomegaly, or an echolucent lesion than among those with normal ultrasonography (15 to 20 versus 6 percent) [<a href="#rid39">39</a>].</p><p></p><p class="headingAnchor" id="H22"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>Important aspects of the physical examination of the child with microcephaly include [<a href="#rid8">8,15,23,26</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>General appearance – Dysmorphic features may suggest a particular syndrome  (<a class="graphic graphic_table graphicRef61045" href="/d/graphic/61045.html" rel="external">table 1</a>). However, facial dysmorphism may be distorted by microcephaly. Congenital microcephaly is usually associated with a sloping forehead and small anterior fontanelle [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>OFC – The OFC should be measured and compared with previous measurements. The severity of microcephaly should be assessed by determining the number of SD below the mean (ie, the z score). The z scores for children younger than two years can be determined by using the following calculators for the World Health Organization (WHO) OFC chart (<a class="calc calc_professional" href="/d/html/15630.html" rel="external">calculator 1</a>) and the Centers for Disease Control and Prevention (CDC) growth chart (<a class="calc calc_professional" href="/d/html/13417.html" rel="external">calculator 2</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Weight and length trajectories – The child's weight and length (or height) should also be measured and plotted on standard curves. The weight and length percentiles should be compared with the OFC percentile. (See  <a class="medical medical_review" href="/d/html/2845.html" rel="external">"Normal growth patterns in infants and prepubertal children", section on 'CDC growth charts'</a>.)</p><p></p><p class="bulletIndent1">Several causes of microcephaly may be associated with postnatal growth failure and/or short stature (eg, Seckel syndrome, Rubinstein-Taybi syndrome).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Head – In addition to measuring the OFC, examination of the head should include assessment of the head shape. In infants, assessment of the fontanelles and palpation of the cranial sutures also should be performed.</p><p></p><p class="bulletIndent1">The anterior fontanelle usually closes between 10 and 24 months. Early closure can be a normal finding but also is associated with microcephaly, craniosynostosis, hyperthyroidism, or hypoparathyroidism. Persistent enlargement of the anterior fontanelle in children with microcephaly may be due to a syndrome (eg, Down syndrome, trisomy 13 or 18, 5p- [cri-du-chat], Rubinstein-Taybi) or toxins.</p><p></p><p class="bulletIndent1">An abnormal head shape and ridges along the suture lines are suggestive of craniosynostosis. Overriding sutures and a prominent occiput is suggestive of fetal disruption sequence. (See  <a class="medical medical_review" href="/d/html/2910.html" rel="external">"Overview of craniosynostosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Eyes – Examination of the eyes may provide clues to intrauterine infection (eg, chorioretinitis, cataract) or metabolic disease (cataract). (See  <a class="medical medical_review" href="/d/html/6270.html" rel="external">"Cataract in children", section on 'Clinical features'</a> and  <a class="medical medical_review" href="/d/html/6011.html" rel="external">"Overview of TORCH infections", section on 'Clinical features of TORCH infections'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Oropharynx – The oropharynx should be examined for single maxillary incisor (characteristic of holoprosencephaly in conjunction with other midline defects of the eyes, nose, and palate [eg, cleft lip or palate, bifid uvula]).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Skin – Examination of the skin may provide clues to intrauterine infection (eg, petechiae and/or jaundice in the newborn) or metabolic disease (eg, eczematous rash in PKU). (See  <a class="medical medical_review" href="/d/html/2919.html" rel="external">"Overview of phenylketonuria"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abdomen – Hepatomegaly or splenomegaly are suggestive of congenital infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neurologic assessment – Neurologic evaluation, including assessment of tone, reflexes, and intellectual/developmental ability. Children with microcephaly are at risk for cerebral palsy and intellectual/developmental disability [<a href="#rid11">11</a>]. Cerebral palsy is common in children with microcephaly, and children with microcephaly are at risk for intellectual/developmental disability. (See  <a class="medical medical_review" href="/d/html/6167.html" rel="external">"Cerebral palsy: Classification and clinical features", section on 'Classification'</a> and  <a class="medical medical_review" href="/d/html/6172.html" rel="external">"Intellectual disability (ID) in children: Clinical features, evaluation, and diagnosis", section on 'Clinical evaluation'</a>.)</p><p></p><p class="headingAnchor" id="H23"><span class="h2">Parental OFC and Weaver curve</span><span class="headingEndMark"> — </span>Parents' occipitofrontal circumference (OFC) measurements should be obtained if possible to assess familial variation in head size [<a href="#rid9">9</a>]. This is particularly true if the microcephaly is between 2 and 3 SD below the mean [<a href="#rid15">15</a>].</p><p>The genetic contribution to microcephaly can be assessed by using the Weaver curve [<a href="#rid8">8,40</a>].</p><p>The Weaver curve helps to determine whether genetic influences contribute to a child's microcephaly [<a href="#rid40">40</a>]. We typically use the Weaver curve in children without syndromic features, with normal development and with OFC &gt;2 SDs and ≤3 SDs below the mean for age and sex and whose parents have normal development without syndromic features.</p><p>To use the Weaver curve:</p><p class="bulletIndent1"><span class="glyph">●</span>A standard score is calculated for the child and each of the parents using the following formula:</p><p></p><div class="formulaContainer"><div class="formula"><p class="bulletIndent2"><span class="glyph">•</span>Standard score (SS) = (OFC - mean value)/SD</p></div></div><p></p><p class="bulletIndent1"><span class="glyph">●</span>The mean values and SD for age and sex are listed in the table  (<a class="graphic graphic_table graphicRef61299" href="/d/graphic/61299.html" rel="external">table 3</a>). In calculating the parents' SSs, the mean value and SD for an 18-year-old should be used.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The intercept of the average of the parents' SS (horizontal axis) and the child's SS (vertical axis) is plotted on the Weaver curve  (<a class="graphic graphic_figure graphicRef119535" href="/d/graphic/119535.html" rel="external">figure 4</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Familial microcephaly is suggested if the child's SS is within the range determined by the average parental SS [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent2">Familial microcephaly may reflect familial variation (ie, the child's head size is normal relative to that of the parents) or autosomal dominant microcephaly. In either case, if the child's OFC is &lt;3 SDs below the mean for age and sex, additional evaluation may be deferred unless the child develops neurologic findings or the microcephaly worsens.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Familial microcephaly is unlikely if the child's SS is below the range determined by the average parental SS score; additional evaluation may be warranted, particularly if the child's OFC is &gt;3 SDs below the mean for age and sex. (See <a class="local">'Diagnostic testing'</a> below.)</p><p></p><p class="headingAnchor" id="H25"><span class="h2">Diagnostic testing</span><span class="headingEndMark"> — </span>Diagnostic testing may be warranted in children with microcephaly and abnormal development or associated clinical findings  (<a class="graphic graphic_algorithm graphicRef94816" href="/d/graphic/94816.html" rel="external">algorithm 1</a>). Testing may include [<a href="#rid6">6,11,14,15,23,26</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Genetic studies if the child has dysmorphic features, unless there is an obvious cause of the microcephaly in a child with OFC &lt;3 SD below the mean – Consultation with a clinical geneticist is suggested to determine the most appropriate testing strategy but will usually include a genomic array, unless there is a readily identifiable syndromic diagnosis. (See  <a class="medical medical_review" href="/d/html/14392.html" rel="external">"Microcephaly: A clinical genetics approach", section on 'Initial genetics consultation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluation for congenital infection – Consultation with a specialist in pediatric infectious diseases is suggested to determine the most appropriate testing strategy. (See  <a class="medical medical_review" href="/d/html/6011.html" rel="external">"Overview of TORCH infections", section on 'Approach to the infant with suspected intrauterine infection'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluation for metabolic disease or storage disorder – This may include testing for amino- and organic acidurias, lactate and/or very-long-chain fatty acids if the infant is hypotonic, or plasma 7-dehydrocholesterol if the infant has features suggestive of Smith-Lemli-Opitz syndrome  (<a class="graphic graphic_table graphicRef61045" href="/d/graphic/61045.html" rel="external">table 1</a>). Consultation with a clinical geneticist is suggested to determine the most appropriate testing strategy. (See  <a class="medical medical_review" href="/d/html/2912.html" rel="external">"Metabolic emergencies in suspected inborn errors of metabolism: Presentation, evaluation, and management", section on 'Initial evaluation'</a> and  <a class="medical medical_review" href="/d/html/17216.html" rel="external">"Inborn errors of metabolism: Identifying the specific disorder", section on 'Laboratory evaluation'</a> and  <a class="medical medical_review" href="/d/html/2927.html" rel="external">"Organic acidemias: An overview and specific defects"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ophthalmology referral – Ophthalmologic examination may provide clues to congenital infection or genetic disease.</p><p></p><p class="headingAnchor" id="H26"><span class="h2">Neuroimaging</span><span class="headingEndMark"> — </span>Neuroimaging studies, which may identify structural causes of microcephaly, are most useful in microcephalic children with abnormal development [<a href="#rid5">5,11</a>]. Most children with symptomatic microcephaly have abnormal neuroimaging [<a href="#rid41">41,42</a>].</p><p>Magnetic resonance imaging (MRI) generally is the preferred imaging modality [<a href="#rid12">12,18,23</a>]. However, computed tomography (CT) may be warranted if craniosynostosis, TORCH infection, or Zika virus infection is suspected because CT is better than MRI in identifying microcalcifications and bone structure. Consultation with a pediatric radiologist may be helpful in planning the evaluation. (See  <a class="medical medical_review" href="/d/html/2910.html" rel="external">"Overview of craniosynostosis", section on 'Computed tomography'</a> and  <a class="medical medical_review" href="/d/html/6011.html" rel="external">"Overview of TORCH infections"</a> and  <a class="medical medical_review" href="/d/html/109681.html" rel="external">"Congenital Zika virus infection: Clinical features, evaluation, and management of the neonate", section on 'Neuroimaging'</a>.)</p><p>In a retrospective series of 680 children with symptomatic microcephaly who presented for pediatric neurology evaluation at two centers in Germany, 299 underwent cranial MRI [<a href="#rid26">26</a>]. Seventy-six percent had abnormal findings, including anomalies of white matter (eg, periventricular leukomalacia, delayed or disturbed myelination) in 40 percent and gyration defects in 14 percent. In another study of 55 children with symptomatic microcephaly, MRI revealed abnormalities in 68 percent of the children with genetic microcephaly and 100 percent of the children with acquired microcephaly (intrauterine or postnatally acquired) [<a href="#rid42">42</a>]. Migrational abnormalities were the most common findings in children with genetic microcephaly. Hydranencephaly and infarction were the most common findings in children with acquired microcephaly.</p><p class="headingAnchor" id="H55603463"><span class="h1">PRENATAL EVALUATION</span><span class="headingEndMark"> — </span>Prenatally, microcephaly is diagnosed by ultrasound examination. We define prenatal microcephaly as head circumference &lt;3 standard deviations (SD) below the mean or below the 2<sup>nd</sup> percentile for gestational age  (<a class="graphic graphic_diagnosticimage graphicRef78619" href="/d/graphic/78619.html" rel="external">image 4</a>) [<a href="#rid43">43-45</a>]; however, the definition is not standardized and some authors use a threshold of &lt;2 SD below the mean. The diagnosis is complicated by limitations in accuracy of head circumference measurements and inconsistency between prenatal and postnatal head circumference growth curves. Although there are reference values for fetal head circumference [<a href="#rid46">46</a>], standards have not been developed for specific populations (eg, based on sex, race/ethnicity) [<a href="#rid47">47</a>].</p><p>The approach to evaluation of prenatal microcephaly depends upon the presence of associated ultrasonographic anomalies, appropriateness of other fetal biometric parameters (eg, length of bones, abdominal circumference) in relation to gestational age, historical features (eg, consanguinity, intrauterine infection), and head circumference measurements of parents and siblings. Associated ultrasonographic anomalies may indicate syndromic microcephaly. (See  <a class="medical medical_review" href="/d/html/6745.html" rel="external">"Prenatal diagnosis of CNS anomalies other than neural tube defects and ventriculomegaly"</a>.)</p><p>Additional evaluation (eg, genetic testing, fetal brain MRI, intrauterine infection) may be obtained if a specific diagnosis is desired to help with pregnancy management. Indications for these evaluations may include:</p><p class="bulletIndent1"><span class="glyph">●</span>Parental consanguinity</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Family members with microcephaly and stigmata of autosomal dominant conditions that include microcephaly  (<a class="graphic graphic_table graphicRef61045" href="/d/graphic/61045.html" rel="external">table 1</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other central nervous system (CNS) and non-CNS morphologic abnormalities that suggest a chromosomal disorder</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Otherwise unexplained fetal microcephaly (eg, family members with normal head circumference and fetal biometric parameters other than head circumference appropriate for gestational age)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Signs of intrauterine infection (eg, intracranial calcifications or ascites) </p><p></p><p>The developmental outcome of prenatal microcephaly depends upon the underlying etiology and associated abnormalities [<a href="#rid48">48</a>].</p><p>If there has been a previously affected child, prenatal assessment includes a level II (high risk) fetal sonogram at 20 weeks to assess anatomy. In fetuses with microcephaly, fetal MRI may be an adjunct to sonography. Consultation with a specialist in maternal-fetal medicine is recommended. Repeat sonogram can be obtained if repeat head measurements are desired later in pregnancy; the timing and frequency of repeat sonography depend upon the indication. However, severe postnatal microcephaly may not be evident on sonogram during the second trimester and may not be apparent until very late in pregnancy or even postnatally [<a href="#rid49">49</a>].</p><p class="headingAnchor" id="H27"><span class="h1">ASSOCIATED NEUROLOGIC IMPAIRMENT</span><span class="headingEndMark"> — </span>The risk of associated neurologic impairment in children with microcephaly depends upon the underlying cause. It is usually increased in children whose microcephaly is part of a wider pattern of malformation (eg, trisomy 13, trisomy 18) and for those with intrauterine infection [<a href="#rid14">14,48</a>]. In a retrospective series of 680 children with microcephaly, most of whom had neurologic symptoms, 65 percent had intellectual disability or developmental delay and 43 percent had epilepsy [<a href="#rid26">26</a>].</p><p>The severity of cognitive impairment is generally related to the severity of microcephaly [<a href="#rid20">20,21,50</a>], as illustrated below:</p><p class="bulletIndent1"><span class="glyph">●</span>In a study of 212 children with microcephaly, median intelligence quotient (IQ) decreased with decreasing occipitofrontal circumference (OFC) (median IQ 35 versus 62 in children with OFC more than 3.9 standard deviations [SD] below the mean and between 2.0 and 2.1 SD below the mean, respectively) [<a href="#rid20">20</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another study, IQ scores in seven-year-old children with OFC more than 3 SD below the mean were more likely to have IQ scores &lt;70 than children with OFC between 2 and 3 SD below the mean (51 versus 11 percent) [<a href="#rid21">21</a>]. None of the children with OFC more than 3 SD below the mean had IQ scores greater than 100.</p><p></p><p>However, individuals with autosomal recessive primary microcephaly, Seckel syndrome, and other primary microcephaly syndromes generally fare better intellectually than would be predicted on the basis of their head circumference. (See  <a class="medical medical_review" href="/d/html/14392.html" rel="external">"Microcephaly: A clinical genetics approach", section on 'Primary genetic microcephaly and its syndromes'</a>.)</p><p>Most children with postnatal-onset microcephaly have poor developmental outcome [<a href="#rid51">51,52</a>]. In a longitudinal cohort of 57 children with postnatal-onset microcephaly who were followed for an average of four years, only 23 percent had a normal developmental quotient [<a href="#rid51">51</a>]. Maintenance of postnatal growth (weight and height) was associated with more favorable developmental outcomes, independent of underlying etiology.</p><p class="headingAnchor" id="H1323859178"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/118550.html" rel="external">"Society guideline links: Microcephaly"</a>.)</p><p class="headingAnchor" id="H28"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitoring head growth</strong> – Head circumference (occipitofrontal circumference [OFC]) should be measured at health maintenance visits between birth and three years of age and in any child with neurologic symptoms. OFC measurements are most informative when plotted over time. (See <a class="local">'Monitoring head growth'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definitions</strong> – Microcephaly is an OFC greater than 2 standard deviations (SD) below the mean for a given age, sex, and gestation. Microcephaly is borderline when the OFC is between 2 and 3 SD below the mean, moderate when the OFC is between 3 and 5 SD below the mean, and severe when the OFC is ≥5 SD below the mean. Microencephaly is an abnormally small brain. (See <a class="local">'Microcephaly'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology</strong> – A variety of genetic abnormalities and environmental insults can affect brain development, resulting in microencephaly and/or microcephaly  (<a class="graphic graphic_table graphicRef75479" href="/d/graphic/75479.html" rel="external">table 2</a>). (See <a class="local">'Etiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postnatal evaluation</strong> – Evaluation for microcephaly should be initiated when a single OFC measurement is more than 2 to 3 SD below the mean (after confirmation that the measurement was accurate) or when serial measurements reveal progressive decrease in head size. (See <a class="local">'Overview of approach'</a> above.)</p><p></p><p class="bulletIndent1">The initial evaluation includes a history and physical examination of the child and parents. Factors that determine the urgency and extent of the ancillary evaluation of microcephaly include  (<a class="graphic graphic_algorithm graphicRef94816" href="/d/graphic/94816.html" rel="external">algorithm 1</a>) (see <a class="local">'Overview of approach'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Age at onset</p><p class="bulletIndent2"><span class="glyph">•</span>History of central nervous system trauma or infection</p><p class="bulletIndent2"><span class="glyph">•</span>Associated symptoms</p><p class="bulletIndent2"><span class="glyph">•</span>Neurodevelopmental abnormalities</p><p class="bulletIndent2"><span class="glyph">•</span>Syndromic features  (<a class="graphic graphic_table graphicRef61045" href="/d/graphic/61045.html" rel="external">table 1</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Family history</p><p></p><p class="bulletIndent1">Consultation with or referral to a clinical geneticist, pediatric neurologist, or specialist in pediatric infectious diseases can be helpful in determining the appropriate studies for the ancillary evaluation. (See <a class="local">'Diagnostic testing'</a> above and <a class="local">'Neuroimaging'</a> above and  <a class="medical medical_review" href="/d/html/14392.html" rel="external">"Microcephaly: A clinical genetics approach", section on 'Initial genetics consultation'</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Stoll C. Problems in the diagnosis of fragile X syndrome in young children are still present. Am J Med Genet 2001; 100:110.</a></li><li><a class="nounderline abstract_t">Zvulunov A, Weitz R, Metzker A. Neurofibromatosis type 1 in childhood: evaluation of clinical and epidemiologic features as predictive factors for severity. Clin Pediatr (Phila) 1998; 37:295.</a></li><li><a class="nounderline abstract_t">Furuta T, Tabuchi A, Adachi Y, et al. Primary brain tumors in children under age 3 years. Brain Tumor Pathol 1998; 15:7.</a></li><li><a class="nounderline abstract_t">Tomita T, McLone DG. Brain tumors during the first twenty-four months of life. Neurosurgery 1985; 17:913.</a></li><li class="breakAll">Nard JA. Abnormal head size and shape. In: Common &amp; Chronic Symptoms in Pediatrics, Gartner JC, Zitelli BJ (Eds), Mosby, St. Louis 1997.</li><li class="breakAll">Fenichel GM. Disorders of cranial volume and shape. In: Clinical Pediatric Neurology: A Signs and Symptoms Approach, 5th ed, Elsevier Saunders, Philadelphia 2005. p.353.</li><li><a class="nounderline abstract_t">Grummer-Strawn LM, Reinold C, Krebs NF, Centers for Disease Control and Prevention (CDC). Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States. MMWR Recomm Rep 2010; 59:1.</a></li><li><a class="nounderline abstract_t">Abuelo D. Microcephaly syndromes. Semin Pediatr Neurol 2007; 14:118.</a></li><li><a class="nounderline abstract_t">Leroy JG, Frías JL. Nonsyndromic microcephaly: an overview. Adv Pediatr 2005; 52:261.</a></li><li><a class="nounderline abstract_t">Opitz JM, Holt MC. Microcephaly: general considerations and aids to nosology. J Craniofac Genet Dev Biol 1990; 10:175.</a></li><li><a class="nounderline abstract_t">Ashwal S, Michelson D, Plawner L, et al. Practice parameter: Evaluation of the child with microcephaly (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2009; 73:887.</a></li><li class="breakAll">Varma R, William, SD, Wessel HB. Neurology. In: Atlas of Pediatric Physical Diagnosis, 5th ed, Zitelli BJ, Davis HW (Eds), Mosby Elsevier, Philadelphia 2007. p.563.</li><li><a class="nounderline abstract_t">Roche AF, Mukherjee D, Guo SM, Moore WM. Head circumference reference data: birth to 18 years. Pediatrics 1987; 79:706.</a></li><li><a class="nounderline abstract_t">Rios A. Microcephaly. Pediatr Rev 1996; 17:386.</a></li><li class="breakAll">Firth HV, Hurst JA, Hall JG. Microcephaly. In: Oxford Desk Reference: Clinical Genetics, 1st ed, Oxford University Press, Oxford 2005. p.172.</li><li><a class="nounderline abstract_t">Woods CG. Human microcephaly. Curr Opin Neurobiol 2004; 14:112.</a></li><li><a class="nounderline abstract_t">Leviton A, Holmes LB, Allred EN, Vargas J. Methodologic issues in epidemiologic studies of congenital microcephaly. Early Hum Dev 2002; 69:91.</a></li><li class="breakAll">Gleeson JG, Dobyns WB, Plawner L, Ashwal S. Congenital structural defects. In: Pediatric Neurology Principles and Practice, 4th ed, Swaiman KF, Ashwal S, Ferriero DM (Eds), Mosby Elsevier, Philadelphia 2006. p.399.</li><li><a class="nounderline abstract_t">Avery GB, Meneses L, Lodge A. The clinical significance of "measurement microcephaly". Am J Dis Child 1972; 123:214.</a></li><li><a class="nounderline abstract_t">Pryor HB, Thelander H. Abnormally small head size and intellect in children. J Pediatr 1968; 73:593.</a></li><li><a class="nounderline abstract_t">Dolk H. The predictive value of microcephaly during the first year of life for mental retardation at seven years. Dev Med Child Neurol 1991; 33:974.</a></li><li><a class="nounderline abstract_t">Sells CJ. Microcephaly in a normal school population. Pediatrics 1977; 59:262.</a></li><li class="breakAll">Menkes JH, Sarnat HB, Flores-Sarnat L. Malformations of the central nervous system. In: Child Neurology, 7th ed, Menkes JH, Sarnat HB, Maria BL (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.284.</li><li><a class="nounderline abstract_t">Kerr SM, Van Bennekom CM, Mitchell AA. Risk factors for congenital microcephaly in the pre-Zika era. Birth Defects Res 2019; 111:96.</a></li><li><a class="nounderline abstract_t">Mochida GH, Walsh CA. Molecular genetics of human microcephaly. Curr Opin Neurol 2001; 14:151.</a></li><li><a class="nounderline abstract_t">von der Hagen M, Pivarcsi M, Liebe J, et al. Diagnostic approach to microcephaly in childhood: a two-center study and review of the literature. Dev Med Child Neurol 2014; 56:732.</a></li><li><a class="nounderline abstract_t">Nunez C, Morris A, Hansen M, Elliott EJ. Microcephaly in Australian infants: A retrospective audit. J Paediatr Child Health 2022; 58:448.</a></li><li><a class="nounderline abstract_t">Garcia CA, Duncan C. Atelencephalic microcephaly. Dev Med Child Neurol 1977; 19:227.</a></li><li><a class="nounderline abstract_t">Russell LJ, Weaver DD, Bull MJ, Weinbaum M. In utero brain destruction resulting in collapse of the fetal skull, microcephaly, scalp rugae, and neurologic impairment: the fetal brain disruption sequence. Am J Med Genet 1984; 17:509.</a></li><li><a class="nounderline abstract_t">Villó N, Beceiro J, Cebrero M, de Frias EG. Fetal brain disruption sequence in a newborn infant with a history of cordocentesis at 21 weeks gestation. Arch Dis Child Fetal Neonatal Ed 2001; 84:F63.</a></li><li><a class="nounderline abstract_t">Bönnemann CG, Meinecke P. Fetal brain disruption sequence: a milder variant. J Med Genet 1990; 27:273.</a></li><li><a class="nounderline abstract_t">Moore CA, Weaver DD, Bull MJ. Fetal brain disruption sequence. J Pediatr 1990; 116:383.</a></li><li><a class="nounderline abstract_t">Corona-Rivera JR, Corona-Rivera E, Romero-Velarde E, et al. Report and review of the fetal brain disruption sequence. Eur J Pediatr 2001; 160:664.</a></li><li><a class="nounderline abstract_t">Holmes LB, Harvey EA, Coull BA, et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001; 344:1132.</a></li><li><a class="nounderline abstract_t">Spohr HL, Willms J, Steinhausen HC. Prenatal alcohol exposure and long-term developmental consequences. Lancet 1993; 341:907.</a></li><li><a class="nounderline abstract_t">Skull SA, Ruben AR, Walker AC. Malnutrition and microcephaly in Australian aboriginal children. Med J Aust 1997; 166:412.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Zika virus. Congenital Microcephaly Case Definitions. http://www.cdc.gov/zika/public-health-partners/microcephaly-case-definitions.html (Accessed on April 06, 2016).</li><li><a class="nounderline abstract_t">Baxter PS, Rigby AS, Rotsaert MH, Wright I. Acquired microcephaly: causes, patterns, motor and IQ effects, and associated growth changes. Pediatrics 2009; 124:590.</a></li><li><a class="nounderline abstract_t">Krishnamoorthy KS, Kuban KC, O'Shea TM, et al. Early cranial ultrasound lesions predict microcephaly at age 2 years in preterm infants. J Child Neurol 2011; 26:188.</a></li><li><a class="nounderline abstract_t">Weaver DD, Christian JC. Familial variation of head size and adjustment for parental head circumference. J Pediatr 1980; 96:990.</a></li><li><a class="nounderline abstract_t">Custer DA, Vezina LG, Vaught DR, et al. Neurodevelopmental and neuroimaging correlates in nonsyndromal microcephalic children. J Dev Behav Pediatr 2000; 21:12.</a></li><li><a class="nounderline abstract_t">Sugimoto T, Yasuhara A, Nishida N, et al. MRI of the head in the evaluation of microcephaly. Neuropediatrics 1993; 24:4.</a></li><li><a class="nounderline abstract_t">Chervenak FA, Jeanty P, Cantraine F, et al. The diagnosis of fetal microcephaly. Am J Obstet Gynecol 1984; 149:512.</a></li><li><a class="nounderline abstract_t">Chervenak FA, Rosenberg J, Brightman RC, et al. A prospective study of the accuracy of ultrasound in predicting fetal microcephaly. Obstet Gynecol 1987; 69:908.</a></li><li><a class="nounderline abstract_t">Kurtz AB, Wapner RJ, Rubin CS, et al. Ultrasound criteria for in utero diagnosis of microcephaly. J Clin Ultrasound 1980; 8:11.</a></li><li><a class="nounderline abstract_t">Kurmanavicius J, Wright EM, Royston P, et al. Fetal ultrasound biometry: 1. Head reference values. Br J Obstet Gynaecol 1999; 106:126.</a></li><li><a class="nounderline abstract_t">Berger I. Prenatal microcephaly: can we be more accurate? J Child Neurol 2009; 24:97.</a></li><li><a class="nounderline abstract_t">Deloison B, Chalouhi GE, Bernard JP, et al. Outcomes of fetuses with small head circumference on second-trimester ultrasonography. Prenat Diagn 2012; 32:869.</a></li><li><a class="nounderline abstract_t">Tolmie JL, McNay M, Stephenson JB, et al. Microcephaly: genetic counselling and antenatal diagnosis after the birth of an affected child. Am J Med Genet 1987; 27:583.</a></li><li><a class="nounderline abstract_t">Raghuram K, Yang J, Church PT, et al. Head Growth Trajectory and Neurodevelopmental Outcomes in Preterm Neonates. Pediatrics 2017; 140.</a></li><li><a class="nounderline abstract_t">Rosman NP, Tarquinio DC, Datseris M, et al. Postnatal-onset microcephaly: pathogenesis, patterns of growth, and prediction of outcome. Pediatrics 2011; 127:665.</a></li><li><a class="nounderline abstract_t">Gordon-Lipkin E, Gentner MB, German R, Leppert ML. Neurodevelopmental Outcomes in 22 Children With Microcephaly of Different Etiologies. J Child Neurol 2017; 32:804.</a></li></ol></div><div id="topicVersionRevision">Topic 2839 Version 41.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11298371" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Problems in the diagnosis of fragile X syndrome in young children are still present.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9597295" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Neurofibromatosis type 1 in childhood: evaluation of clinical and epidemiologic features as predictive factors for severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9879457" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Primary brain tumors in children under age 3 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4080124" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Brain tumors during the first twenty-four months of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4080124" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Brain tumors during the first twenty-four months of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4080124" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Brain tumors during the first twenty-four months of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20829749" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17980308" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Microcephaly syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16124344" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Nonsyndromic microcephaly: an overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2211965" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Microcephaly: general considerations and aids to nosology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19752457" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Practice parameter: Evaluation of the child with microcephaly (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19752457" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Practice parameter: Evaluation of the child with microcephaly (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3575026" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Head circumference reference data: birth to 18 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8937170" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Microcephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8937170" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Microcephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15018946" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Human microcephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12324187" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Methodologic issues in epidemiologic studies of congenital microcephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12324187" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Methodologic issues in epidemiologic studies of congenital microcephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5026200" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : The clinical significance of "measurement microcephaly".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5678001" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Abnormally small head size and intellect in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1743426" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The predictive value of microcephaly during the first year of life for mental retardation at seven years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/834509" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Microcephaly in a normal school population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/834509" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Microcephaly in a normal school population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30584689" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Risk factors for congenital microcephaly in the pre-Zika era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11262728" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Molecular genetics of human microcephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24617602" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Diagnostic approach to microcephaly in childhood: a two-center study and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34553803" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Microcephaly in Australian infants: A retrospective audit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/870360" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Atelencephalic microcephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6702901" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : In utero brain destruction resulting in collapse of the fetal skull, microcephaly, scalp rugae, and neurologic impairment: the fetal brain disruption sequence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11124930" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Fetal brain disruption sequence in a newborn infant with a history of cordocentesis at 21 weeks gestation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2325109" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Fetal brain disruption sequence: a milder variant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2308027" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Fetal brain disruption sequence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11760023" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Report and review of the fetal brain disruption sequence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11297704" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The teratogenicity of anticonvulsant drugs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7681518" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Prenatal alcohol exposure and long-term developmental consequences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9140346" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Malnutrition and microcephaly in Australian aboriginal children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9140346" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Malnutrition and microcephaly in Australian aboriginal children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19651581" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Acquired microcephaly: causes, patterns, motor and IQ effects, and associated growth changes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20724751" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Early cranial ultrasound lesions predict microcephaly at age 2 years in preterm infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7189556" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Familial variation of head size and adjustment for parental head circumference.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10706344" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Neurodevelopmental and neuroimaging correlates in nonsyndromal microcephalic children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8474610" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : MRI of the head in the evaluation of microcephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6742021" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : The diagnosis of fetal microcephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3554067" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : A prospective study of the accuracy of ultrasound in predicting fetal microcephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6766470" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Ultrasound criteria for in utero diagnosis of microcephaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10426678" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Fetal ultrasound biometry: 1. Head reference values.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19168823" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Prenatal microcephaly: can we be more accurate?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22692804" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Outcomes of fetuses with small head circumference on second-trimester ultrasonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3307411" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Microcephaly: genetic counselling and antenatal diagnosis after the birth of an affected child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28759409" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Head Growth Trajectory and Neurodevelopmental Outcomes in Preterm Neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21422087" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Postnatal-onset microcephaly: pathogenesis, patterns of growth, and prediction of outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28482742" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Neurodevelopmental Outcomes in 22 Children With Microcephaly of Different Etiologies.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
